Albendazole is one of the most widely used antiparasitic drugs in the world, prescribed to treat infections ranging from common intestinal worms to serious tissue-dwelling parasites like those responsible for neurocysticercosis and hydatid disease. For most intestinal worm infections, a single 400 mg dose is the standard treatment, though tissue infections can require weeks or months of therapy. The drug is generally well tolerated, but its safety profile, the way food dramatically changes how much of it your body absorbs, and its interactions with other medications all deserve a closer look.
How Albendazole Kills Parasites
Albendazole works by targeting a structural protein called beta-tubulin inside parasitic cells. Beta-tubulin molecules normally link together to form microtubules, tiny scaffolding tubes that cells depend on for dividing, moving nutrients, and maintaining their shape. Albendazole binds to beta-tubulin and prevents those molecules from assembling into microtubules, which stalls cell division and disrupts the parasite’s ability to absorb glucose for energy.1PubMed. Evaluation of the mechanism of action of albendazole on adult rat lungworm (Angiostrongylus cantonensis) Without functioning microtubules, the parasite’s internal transport system breaks down and its cells die.
Research on tapeworms has shown that albendazole and its active metabolite specifically destroy microtubules in the parasite’s outer covering, the tegument, which is the layer responsible for absorbing nutrients and protecting the worm from the host’s immune system.2PLoS Pathogens. Albendazole specifically disrupts microtubules and protein turnover in the tegument of the cestode Mesocestoides corti Human cells also use beta-tubulin, but albendazole binds much more strongly to the parasite version, which is why it can kill worms at doses that leave your own tissues largely unaffected.
Intestinal Worm Infections
The most common reason people take albendazole is to treat soil-transmitted helminths, the group of intestinal worms that includes roundworm (Ascaris), hookworm, and whipworm (Trichuris). These infections affect over a billion people globally, mostly in tropical and subtropical regions with limited sanitation.
Against roundworm, albendazole is highly effective. Studies in endemic areas have reported cure rates above 80% with egg counts dropping by more than 95% after a single 400 mg dose.3PubMed. Efficacy of mebendazole and albendazole for Ascaris lumbricoides and hookworm infections in an area with long time exposure for antihelminthes, Northwest Ethiopia Against hookworm, the picture is a little less tidy. A dose-finding trial across children and adults in Côte d’Ivoire found cure rates between roughly 50% and 75% depending on the age group, with school-aged children responding best.4PubMed Central. Efficacy and Safety of Albendazole in Hookworm-infected Preschool-aged Children, School-aged Children, and Adults in Côte d’Ivoire: A Phase 2 Randomized, Controlled Dose-finding Trial
Whipworm is the parasite that gives albendazole the most trouble. A single 400 mg dose often fails to clear the infection, and researchers have been exploring combination treatments to fill this gap. A head-to-head trial found that pairing albendazole with oxantel pamoate cured about two-thirds of children with whipworm, while albendazole combined with ivermectin cured about a quarter, both significantly outperforming mebendazole given alone.5PubMed. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial A meta-analysis similarly confirmed that adding ivermectin to albendazole roughly halved the risk of persistent whipworm infection compared to albendazole alone, though the combination offered little extra benefit for roundworm and hookworm.6PLoS Neglected Tropical Diseases. Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis
Beyond soil-transmitted worms, albendazole is also used for cutaneous larva migrans, the itchy, snake-like skin rash caused by animal hookworm larvae burrowing under the skin. A seven-day course of 400 mg daily typically clears both the rash and the itching.7Annals of Medicine and Surgery. Cutaneous larva migrans: A case report successfully treated with albendazole
Tissue Infections That Require Longer Treatment
Albendazole’s ability to penetrate tissues makes it one of the few drugs that can reach parasites lodged deep inside organs. Two of the most important tissue infections it treats are neurocysticercosis and hydatid disease.
Neurocysticercosis
Neurocysticercosis occurs when pork tapeworm larvae settle in the brain, forming cysts that can trigger seizures, headaches, and other neurological problems. A Cochrane review found that albendazole probably increases the rate at which brain cysts resolve completely and speeds their transition from active to inactive stages.8Cochrane Database of Systematic Reviews. Anthelmintics for people with neurocysticercosis In a randomized trial, about 31% of albendazole-treated patients were free of active cysts within one month compared to 7% on placebo, and most of that benefit appeared during the first 30 days of treatment.9Journal of Neurology, Neurosurgery & Psychiatry. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial
A longitudinal analysis found that albendazole roughly tripled the speed at which cysts moved from the active phase to the degenerative phase and nearly doubled the speed of their final disappearance.10Transactions of The Royal Society of Tropical Medicine and Hygiene. A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models The treatment appeared strongest in patients who had multiple cysts in different locations and who did not already have calcified lesions. One important caveat: killing cysts in the brain can temporarily worsen inflammation and symptoms, so treatment is typically paired with corticosteroids and antiseizure drugs under close medical supervision. Albendazole had little effect on cysts that were already calcified or in the transitional stage.9Journal of Neurology, Neurosurgery & Psychiatry. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial
Hydatid Disease
Hydatid disease (echinococcosis) forms large cysts, usually in the liver or lungs, caused by dog tapeworm larvae. Treatment often involves surgery to remove the cysts, followed by albendazole to kill any remaining parasite tissue and prevent recurrence. A long-term follow-up study of 70 patients found that combination therapy with albendazole and praziquantel, whether given after surgery or as the sole treatment, led to significant cyst shrinkage and calcification over time. Relapses occurred in about 11% of patients within six months of finishing treatment, but additional albendazole courses resolved those cases over the following years.11PubMed. Long-term evaluation of patients with hydatidosis treated with albendazole and praziquantel For hydatid disease, treatment courses typically span months and are managed with regular imaging and blood tests.
Why a Fatty Meal Matters
Albendazole is poorly absorbed on its own. Your gut converts it into an active metabolite called albendazole sulfoxide, which does the actual work in your bloodstream. How much of that metabolite reaches effective levels depends heavily on what you eat around the time you take the pill.
A study in healthy volunteers found that a high-fat breakfast roughly doubled the blood levels of both albendazole and its active metabolite compared to a low-fat breakfast.12PubMed Central. High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects Separate research confirmed that food in general, whether a heavy or light meal, enhanced systemic availability of the active metabolite by more than twofold compared to fasting.13PubMed Central. Assessment of Diet-Related Changes on Albendazole Absorption, Systemic Exposure, and Pattern of Urinary Excretion in Treated Human Volunteers This has real implications for mass drug administration programs in low-income countries, where children might receive albendazole at school without having eaten. Taking the drug on an empty stomach could mean sub-therapeutic levels actually reach the parasites.
For intestinal worms, absorption matters less because the drug acts partly inside the gut before being absorbed. But for tissue infections like neurocysticercosis or hydatid disease, where the drug needs to travel through the blood to reach cysts in the brain or liver, taking albendazole with a fatty meal is not optional advice. It is the difference between an effective dose and a potentially wasted one.
Common and Rare Side Effects
For single-dose treatment of intestinal worms, albendazole is remarkably well tolerated. In a large-scale school deworming program in Kenya, about a quarter of children reported at least one side effect, most commonly stomach pain, dizziness, or nausea. The vast majority of those reactions were mild and resolved on their own.14PLoS ONE. A School-Based Cross-Sectional Survey of Adverse Events following Co-Administration of Albendazole and Praziquantel for Preventive Chemotherapy against Urogenital Schistosomiasis and Soil-Transmitted Helminthiasis in Kwale County, Kenya A separate school-based program found that minor side effects such as stomach ache, headache, and cough were temporary and manageable without medical referral.15African Journal of Health Sciences. The adverse effects of albendazole and praziquantel in mass drug administration by trained schoolteachers
A dose-escalation trial in children and adults also found the drug safe across multiple dosage levels, with about 18% of participants reporting any adverse event within three hours of taking the drug and almost none reporting anything at the 24-hour mark.16The Lancet. Efficacy and safety of ascending dosages of albendazole against Trichuris trichiura in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trial
Longer treatment courses carry more risk. When albendazole is taken for weeks or months (as in hydatid disease or neurocysticercosis), rare but serious adverse effects can include low white blood cell counts, anemia, and elevated liver enzymes. Reported incidence rates for these are quite low: less than 0.05% for low white cells and about 0.035% for liver enzyme elevation.17PubMed Central. Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis In exceedingly rare cases, severe drops in all blood cell lines (pancytopenia) have been reported, more often in patients who already had underlying liver disease. Deaths from this complication, while documented, are very unusual. Doctors monitoring patients on prolonged albendazole courses typically order regular blood counts and liver function tests.
Drug Interactions Worth Knowing
Albendazole’s active metabolite is processed by liver enzymes, which means other drugs that speed up or slow down those enzymes can change how much active drug stays in your system. A pharmacokinetic review identified several clinically relevant interactions.18PubMed. A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole
- Anticonvulsants: Phenytoin, carbamazepine, and phenobarbital all reduce albendazole blood levels. This matters because patients with neurocysticercosis are often on these seizure medications at the same time they need albendazole therapy.
- Dexamethasone: This corticosteroid slows the elimination of albendazole’s active metabolite, effectively raising its levels. Since dexamethasone is routinely given alongside albendazole in neurocysticercosis treatment to control inflammation, this interaction actually works in the patient’s favor.19PubMed. Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone
- Praziquantel: Increases albendazole levels, which is relevant when the two are combined for hydatid disease or other infections.
- Ritonavir: This HIV protease inhibitor decreases albendazole levels, a concern for patients being treated for parasitic co-infections.
- Cimetidine: Extends the time albendazole stays in the body by increasing its half-life.
The interaction with anticonvulsants is the one clinicians worry about most, because it can reduce albendazole to ineffective levels in exactly the patients who need it for brain cysts. Dose adjustments or drug-level monitoring may be needed in these situations.
Safety During Pregnancy and in Young Children
Albendazole has historically been avoided during the first trimester of pregnancy because animal studies showed it could cause birth defects at high doses. However, a randomized controlled trial in Uganda that tracked pregnant women who received deworming treatment found no effect on perinatal death rates or congenital anomalies.20PubMed Central. Effects of Deworming during Pregnancy on Maternal and Perinatal Outcomes in Entebbe, Uganda: A Randomized Controlled Trial The World Health Organization now considers albendazole acceptable after the first trimester in settings where worm infections threaten maternal health, though many national guidelines remain cautious. A pregnancy test before starting long-term treatment is standard practice in most clinical settings.
In children, the drug has been widely used down to age one in mass deworming campaigns, with side-effect profiles similar to those in older children and adults. The dose-finding trial mentioned earlier included preschool-aged children and found the drug safe across multiple dose levels.16The Lancet. Efficacy and safety of ascending dosages of albendazole against Trichuris trichiura in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trial For children under one year, or those with significant liver disease, clinical judgment and specialist input are typically recommended before prescribing.
The Growing Concern About Resistance
Albendazole and its close relatives belong to a drug class called benzimidazoles. In veterinary medicine, resistance to benzimidazoles is well established in livestock parasites and has been documented for decades. In humans, the question of whether something similar is happening is harder to answer, but the signals are not reassuring.
Resistance in this drug class is linked to mutations in the beta-tubulin gene of the parasite, the same protein albendazole targets.21PubMed Central. Quantitative tests of albendazole resistance in Caenorhabditis elegans beta-tubulin mutants Specific changes at a handful of positions in this gene are known markers for resistance. A study examining whipworm from treated populations in Haiti, Kenya, and Panama found that before treatment, the resistance-associated genetic variant at one key position was present in only about 3% of parasite eggs. After albendazole treatment, that figure jumped to over 55%, a dramatic shift indicating that treatment was selecting for worms carrying the resistance mutation.22PLOS Neglected Tropical Diseases. Association between Response to Albendazole Treatment and β-Tubulin Genotype Frequencies in Soil-transmitted Helminths
Complicating matters, some hookworm species appear able to develop resistance through mechanisms not involving the well-known beta-tubulin mutations at all, suggesting there may be additional routes to resistance that researchers have not yet fully mapped.23PubMed. Albendazole resistance induced in Ancylostoma ceylanicum is not due to single-nucleotide polymorphisms (SNPs) at codons 167, 198, or 200 of the beta-tubulin gene, indicating another resistance mechanism With mass deworming programs distributing hundreds of millions of albendazole doses each year, the selection pressure on parasites is enormous. The drug pipeline for new human anthelmintics is thin, so losing albendazole’s effectiveness would be a serious public health setback.
Cost and Access
Albendazole occupies an unusual position in global health. It is donated in massive quantities for mass deworming and lymphatic filariasis programs, making it essentially free at the point of delivery in many low-income countries. In the United States, the situation is very different. A retrospective analysis of U.S. military prescribing data found that annual spending on anthelmintic medications increased 16-fold over the study period, climbing to nearly $5 million in a single year, with albendazole accounting for more than three quarters of total costs despite representing only about 40% of prescriptions.24PubMed Central. Costs and Prescribing Patterns of Anthelmintics in the United States Military: A Retrospective Analysis The price increases in the U.S. are driven by the limited number of manufacturers and the relatively small domestic market for antiparasitic drugs. For patients paying out of pocket or through insurance in high-income countries, the cost can be surprisingly steep for a drug that costs pennies to produce.
Early Research on Anti-Cancer Properties
Because albendazole disrupts microtubules, and microtubule-targeting drugs are already a cornerstone of cancer chemotherapy, researchers have been curious about whether this cheap antiparasitic might have antitumor effects. Laboratory work on head and neck cancer cell lines found that albendazole inhibited cell growth in the vast majority of tested lines, triggering cell death, halting the cell cycle, and blocking cell migration at very low concentrations. Normal control cells were not measurably affected at the doses tested.25PubMed Central. Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer Other research groups have reported similar findings in cell lines and animal models for various cancer types.26PubMed Central. Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
The enthusiasm here deserves some caution. Killing cancer cells in a dish is a much lower bar than shrinking tumors in a living person. Albendazole’s poor absorption and rapid metabolism mean that achieving and maintaining the blood levels needed for anticancer activity would be a challenge. No large-scale clinical trials in humans have yet proven that albendazole is an effective cancer treatment. The research is in its early stages, and while the drug’s low cost and established safety profile make it an attractive candidate for further study, it would be premature to call it a cancer therapy.